With more than 40 million men dealing with an enlarged prostate (BPH), chances are either you or someone you know is experiencing the frequent urge to go to the bathroom or slowed urinary flow. For 69 ...

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...

WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced the publication of ...

A new medical device offers an alternative to open surgery and drugs for the treatment of benign prostatic hyperplasia. A new medical device offers a less invasive way to treat symptoms caused by an ...

NEW YORK (CBSNewYork)-- There is a new procedure to help men who go to the bathroom several times a night. CBS2's Dr. Max Gomez reports an enlarged prostate can usually be treated with medication, a ...

1. Dr. Mally was recognized for his high level of training and experience with NeoTract's UroLift System. He uses the system to treat symptoms associated with benign prostatic hyperplasia. 2. The ...

Associated Urologists of Nashville (Tenn.) urologist Benjamin Dehner, MD, was named a UroLift Center of Excellence. 1. Dr. Dehner was recognized for his high level of training and experience with ...

Teleflex IncorporatedTFX recently released favorable results of multiple studies on the company's minimally invasive treatment for enlarged prostate, also known as BPH (benign prostatic hyperplasia).

WAYNE, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for the ...